Damora Therapeutics reported earnings of -$ 0.40 per DMRA share on Nov 4, 2026, falling short of analysts' expectations by
| Report Date | Nov 4, 2026 |
|---|---|
| Forecasted EPS | -$ 0.48 |
| Earnings Per Share (Surprise) | -$ 0.40 (+$ 0.08251) |
| Last Year's EPS | -$ 2.53 |
| EPS YoY Change |
Out of the last 14 earnings reporting periods, Damora Therapeutics beat analysts’ expectations 8 times and fell short of expectations 4 time(s). Damora Therapeutics reported earnings per share of -$ 0.40 in the last report surpassing an estimated EPS of -$ 0.48 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 4, 2026 | -$ 0.48 | -$ 0.40 | -$ 2.36 | |
| Aug 11, 2026 | -$ 0.41 | -$ 0.39 | -$ 2.60 | |
| May 12, 2026 | -$ 0.21 | -$ 0.62 | -$ 1.92 | |
| Mar 18, 2026 | -$ 0.14 | -$ 3.24 | -$ 5.22 | |
| Nov 6, 2025 | -$ 0.10 | -$ 2.36 | -$ 3.39 | |
| Aug 5, 2025 | - | -$ 2.60 | -$ 4.92 | |
| May 8, 2025 | - | -$ 1.92 | -$ 5.05 | |
| Mar 19, 2025 | -$ 2.97 | -$ 5.22 | -$ 5.97 | |
| Nov 1, 2024 | -$ 3.70 | -$ 3.39 | -$ 13.75 | |
| Aug 12, 2024 | -$ 6.04 | -$ 4.92 | -$ 13.25 | |
| Apr 29, 2024 | -$ 10.25 | -$ 5.05 | - | - |
| Mar 8, 2024 | -$ 8.75 | -$ 5.97 | - | - |
| Mar 9, 2023 | -$ 14.25 | -$ 13.75 | - | - |
| Feb 18, 2022 | -$ 14.00 | -$ 13.25 | - | - |
Damora Therapeutics’s stock was trading at $ 22.08 on Nov 3, 2026 a day before the last earnings report was released.Following the release of the earnings report, DMRA’s price decreased to $ 21.86 on Nov 5, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 4, 2026 | -$ 0.40 | $ 22.08 | $ 21.86 | |
| Aug 11, 2026 | -$ 0.39 | $ 29.54 | $ 31.00 | |
| May 12, 2026 | -$ 0.62 | $ 24.36 | $ 24.16 | |
| Mar 18, 2026 | -$ 3.24 | $ 24.01 | $ 19.20 |
Damora Therapeutics released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Damora Therapeutics beat analysts’ expectations during the last earnings period by
